These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 12648471)

  • 1. ErbB-targeted therapeutic approaches in human cancer.
    Arteaga CL
    Exp Cell Res; 2003 Mar; 284(1):122-30. PubMed ID: 12648471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The epidermal growth factor receptor-tyrosine kinase: a promising therapeutic target in solid tumors.
    Ritter CA; Arteaga CL
    Semin Oncol; 2003 Feb; 30(1 Suppl 1):3-11. PubMed ID: 12644979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of epidermal growth factor receptor biology and its role as a therapeutic target in human neoplasia.
    Arteaga CL
    Semin Oncol; 2002 Oct; 29(5 Suppl 14):3-9. PubMed ID: 12422308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epidermal growth factor receptor: from mutant oncogene in nonhuman cancers to therapeutic target in human neoplasia.
    Arteaga CL
    J Clin Oncol; 2001 Sep; 19(18 Suppl):32S-40S. PubMed ID: 11560969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The erbB family: targets for therapeutic development against cancer and therapeutic strategies using monoclonal antibodies and tyrosine kinase inhibitors.
    Rowinsky EK
    Annu Rev Med; 2004; 55():433-57. PubMed ID: 14746530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epidermal growth factor receptors (EGFR): a new target for anticancer therapy].
    Gainet M; Guardiola E; Dufresne A; Pivot X
    Cancer Radiother; 2003 Jun; 7(3):195-9. PubMed ID: 12834777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational bases for the development of EGFR inhibitors for cancer treatment.
    Bianco R; Gelardi T; Damiano V; Ciardiello F; Tortora G
    Int J Biochem Cell Biol; 2007; 39(7-8):1416-31. PubMed ID: 17596994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical update and emerging trends in epidermal growth factor receptor targeting in cancer.
    Baselga J; Arteaga CL
    J Clin Oncol; 2005 Apr; 23(11):2445-59. PubMed ID: 15753456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor receptor pathway inhibitors.
    Baselga J; Cortes J
    Cancer Chemother Biol Response Modif; 2005; 22():205-23. PubMed ID: 16110613
    [No Abstract]   [Full Text] [Related]  

  • 10. Epidermal growth factor receptor biology (IMC-C225).
    Kim ES; Khuri FR; Herbst RS
    Curr Opin Oncol; 2001 Nov; 13(6):506-13. PubMed ID: 11673692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the epidermal growth factor receptor in the treatment of colorectal carcinoma.
    Waxman ES; Herbst RS
    Semin Oncol Nurs; 2002 May; 18(2 Suppl 2):20-9. PubMed ID: 12053861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on epidermal growth factor receptor inhibitors.
    Modi S; Seidman AD
    Curr Oncol Rep; 2002 Jan; 4(1):47-55. PubMed ID: 11734113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ErbB receptor family: a therapeutic target for cancer.
    de Bono JS; Rowinsky EK
    Trends Mol Med; 2002; 8(4 Suppl):S19-26. PubMed ID: 11927283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-epidermal growth factor receptor drugs in cancer therapy.
    Ciardiello F; Tortora G
    Expert Opin Investig Drugs; 2002 Jun; 11(6):755-68. PubMed ID: 12036420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small molecule inhibitors targeting the EGFR/ErbB family of protein-tyrosine kinases in human cancers.
    Roskoski R
    Pharmacol Res; 2019 Jan; 139():395-411. PubMed ID: 30500458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the epidermal growth factor receptor (EGFR)--a new therapeutic option in oncology?
    Mamot C; Rochlitz C
    Swiss Med Wkly; 2006 Jan; 136(1-2):4-12. PubMed ID: 16597093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational design of potent and selective EGFR tyrosine kinase inhibitors as anticancer agents.
    Ghosh S; Liu XP; Zheng Y; Uckun FM
    Curr Cancer Drug Targets; 2001 Aug; 1(2):129-40. PubMed ID: 12188886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor receptor targeting in cancer.
    Mendelsohn J; Baselga J
    Semin Oncol; 2006 Aug; 33(4):369-85. PubMed ID: 16890793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGF receptor as a therapeutic target.
    Levitzki A
    Lung Cancer; 2003 Aug; 41 Suppl 1():S9-14. PubMed ID: 12867057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of an anti-epidermal growth factor receptor in treating cancer.
    Waksal HW
    Cancer Metastasis Rev; 1999; 18(4):427-36. PubMed ID: 10855786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.